Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kreuter (Heidelberg, Germany), F. Bonella (Essen, Germany), N. Blank (Heidelberg, Germany), E. Siegert (Berlin, Germany), J. Henes (Tuebingen, Germany), M. Worm (Berlin, Germany), C. Sunderkoetter (Muenster, Germany), M. Schmalzing (Wuerzburg, Germany), A. Kreuter (Oberhausen, Germany), C. Guenther (Dresden, Germany), L. Susok (Bochum, Germany), G. Zeidler (Treuenbrietzen, Germany), I. Koetter (Hamburg, Germany), U. Mueller-Ladner (Bad Nauheim, Germany), T. Krieg (Cologne, Germany), A. Juche (Berlin, Germany), T. Schmeiser (Wuppertal, Germany), G. Riemekasten (Luebeck, Germany), E. Aberer (Graz, Austria), N. Gaebelein-Wissing (Wuppertal, Germany), J. Distler (Erlangen, Germany), M. Sárdy (Munich, Germany), C. Pfeiffer (Ulm, Germany), K. Kuhr (Cologne, Germany), H. Lorenz (Heidelberg, Germany), P. Moinzadeh (Cologne, Germany), N. Hunzelmann (Cologne, Germany). Long term outcomes of immunomodulatory drugs in SSc-ILD - data from the German SSc-network. 5185

Member's Comments

No comment yet.

Related content which might interest you: Long term macrolide antibiotics for the treatment of bronchiectasis in adults - individual participant data meta-analysis Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections Year: 2019 Long term outcome of PAH therapy - the past and the future Source: Annual Congress 2008 - Current and future pulmonary arterial hypertension combination therapy Year: 2008 Long term efficacy and safety of omalizumab in patients with allergic asthma-A real life study Source: Virtual Congress 2020 – Monoclonal antibodies in asthma Year: 2020 Late Breaking Abstract - The outcome of COVID-19 in interstitial lung disease patients treated with anti-inflammatory drugs and antiviral drugs Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 Functional effects of long term ICS treatment in controlled asthma Source: Annual Congress 2011 - Asthma: control and treatment Year: 2011 Correlation of response to antifibrotic treatment with adverse events to antifibrotic drugs in IPF patients from the real-world EMPIRE registry Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis Year: 2020 COVID-19 risk and outcomes in adult asthmatics treated with biologics or systemic corticosteroids: nationwide real-world evidence. Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 Clinical benefits and safety of long term treatment with Montelukast in children with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 525s Year: 2002 Participation in the ARGA study: Long term impact on asthma management Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD Year: 2012 Clinical benefits and safety of long term treatment with montelukast (M) in patients with mild-to-moderate asthma Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001 Use of antidepressive agents in COPD patients: experience in a large Canadian cohort Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 Long term oxygen therapy: compliance and disability among patients Source: Eur Respir J 2002; 20: Suppl. 38, 256s Year: 2002 Safety and tolerability to long term moxifloxacin treatment in 38 patients with difficult to manage tuberculosis: preliminary data Source: Eur Respir J 2004; 24: Suppl. 48, 723s Year: 2004 One-year coverage by inhaled steroids in asthma: French claims data Source: International Congress 2016 – Asthma: treatment, disease control, and quality of life Year: 2016 Anti-inflammatory asthma therapy adherence in paediatric patients: The PACMAN cohort study Source: Annual Congress 2010 - Management of airway disease Year: 2010 Persistence to COPD therapies and impact on exacerbations: a French claims data study Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections Year: 2018 Audit of long term azithromycin therapy in clinical practice Source: Annual Congress 2010 - Treatment and risk factors in lower respiratory tract infections Year: 2010 Long Term Sirolimus therapy for LAM: a real life experience Source: International Congress 2017 – Rare diseases Year: 2017 Short and long term effects of PR. Can patients benefit of a short maintenance program? Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients Year: 2008 Long term effect of doxycycline in asthma: a real world observation Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017